John Patrick Shannon Jr's Net Worth
$5.19 Million
Who is John Patrick Shannon Jr?
John Patrick Shannon Jr has an estimated net worth of $5.19 Million. This is based on reported shares across multiple companies, which include Xeris Biopharma Holdings, Inc., XERIS PHARMACEUTICALS INC, and Durata Therapeutics, Inc..
SEC CIK
John Patrick Shannon Jr's CIK is 0001553595
Past Insider Trading and Trends
2021 was John Patrick Shannon Jr's most active year for acquiring shares with 11 total transactions. John Patrick Shannon Jr's most active month to acquire stocks was the month of September. 2021 was John Patrick Shannon Jr's most active year for disposing of shares, totalling 8 transactions. John Patrick Shannon Jr's most active month to dispose stocks was the month of September. 2013 saw John Patrick Shannon Jr paying a total of $149,800.00 for 20,000 shares, this is the most they've acquired in one year. In 2021 John Patrick Shannon Jr cashed out on 692,349 shares for a total of $0.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Xeris Biopharma Holdings, Inc. (XERS) Snapshot price: $2.625
See Remarks
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +53.25% | 750K |
—
|
—
| 2.16M |
Jan 31
| |||
Form 4
| +2.23% | 30.77K |
$1.64 | $50,399.62 | 1.41M |
Nov 17
| |||
Form 4
| +119.46% | 750K |
—
|
—
| 1.38M |
Jan 31
| |||
Form 4
| +67.77% | 250K |
—
|
—
| 618.91K |
Jan 3
| |||
Form 4
| +37.90% | 100K |
$2.10 | $209,500.00 | 363.83K |
Nov 11 - Nov 12
| |||
Form 4
|
∞
| 263.83K |
—
|
—
| 263.83K |
Oct 5
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
XERIS PHARMACEUTICALS INC No price found
See Remarks
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -263.83K |
—
|
—
|
0
|
Oct 5
| |||
Form 4
| +123.74% | 150K |
—
|
—
| 271.22K |
Jan 29
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 18
| |||
Form 4
| +3.18% | 3.73K |
$2.26 | $8,432.06 | 121.22K |
Jun 30
| |||
Form 4
| +23.04% | 22K |
$3.55 | $77,994.40 | 117.49K |
May 13
| |||
Form 4
| +9.00% | 7.89K |
$3.20 | $25,219.43 | 95.49K |
May 8
| |||
Form 4
| +287.52% | 65K |
—
|
—
| 87.61K |
Jan 31
| |||
Form 4
| +114.10% | 12.05K |
$4.15 | $49,999.20 | 22.61K |
Feb 14
| |||
Form 4
| +4.33% | 438 |
$5.99 | $2,623.62 | 10.56K |
Dec 31
| |||
Form 4
| +12.67% | 1.14K |
$9.72 | $11,061.36 | 10.12K |
Jul 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 31
| |||
Form 4
|
∞
| 8.98K |
—
|
—
| 8.98K |
Jun 25
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Durata Therapeutics, Inc. No price found
Chief Commercial Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -11.00K |
—
|
—
|
0
|
Nov 17
| |||
Form 4
| +37.50% | 3K |
$13.72 | $41,160.00 | 11K |
Aug 12
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 21
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 12
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||